Scientific paper - Original scientific paper
TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
Biomedicines, 10 (2022), 9; 2240. https://doi.org/10.3390/biomedicines10092240


Cite this document

Baranašić, J., Šutić, M., Catalano, C., Drpa, G., Huhn, S., Majhen, D. ... Knežević, J. (2022). TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines, 10. (9). doi: 10.3390/biomedicines10092240

Baranašić, Jurica, et al. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line." Biomedicines, vol. 10, no. 9, 2022. https://doi.org/10.3390/biomedicines10092240

Baranašić, Jurica, Maja Šutić, Calogerina Catalano, Gordana Drpa, Stefanie Huhn, Dragomira Majhen, Davor Nestić, et al. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line." Biomedicines 10, no. 9 (2022). https://doi.org/10.3390/biomedicines10092240

Baranašić, J., et al. (2022) 'TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line', Biomedicines, 10(9). doi: 10.3390/biomedicines10092240

Baranašić J, Šutić M, Catalano C, Drpa G, Huhn S, Majhen D, and sur.. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. Biomedicines [Internet]. 2022 September 09 [cited 2024 November 28];10(9). doi: 10.3390/biomedicines10092240

J. Baranašić, et al., "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line", Biomedicines, vol. 10, no. 9, September 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:605296. [Accessed: 28 November 2024]

Please login to the repository to save this object to your list.